TR15 15mg*10vials

Tirzepatide TR15 15mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing a next-generation metabolic research compound that activates two gut hormone pathways simultaneously.

The 15mg single-vial specification offers a moderate concentration step up from the standard 10mg. This formulation is well-suited for medium-dose gradient studies, extended dual-pathway experiments, and researchers looking to reduce the number of vials needed for longer experimental timelines. The higher content per vial provides greater preparation flexibility for dose escalation protocols.

Through combined GLP-1 and GIP receptor activation, this compound supports research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides a broader scope for studying systemic metabolic regulation compared to single-receptor compounds.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a certificate of analysis provided.

10 vials per pack, designed for medium-scale laboratory research and extended dual-pathway metabolic studies.